Tesofensine
Sinonimi:(1R,2R,3S,5S)-3-(3,4-Dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane; [1R-(2-endo,3-exo)]-3-(3,4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane; NS 2330;
N. CAS:195875-84-4
Formula molecolare: C17H23Cl2NO
Peso molecolare: 328.277
Densità: 1.161 g/cm3
Punto di ebollizione: 396.6°C a 760 mmHg
punto d'infiammabilità: 193.7C
Solubilità:Chloroform (Slightly), Methanol (Slightly)
Aspetto esteriore: Off-White to Light Yellow Sticky Solid
Tesofensine is a serotonin-norepinephrine-dopamine reuptake inhibitor,which is is currently in clinical development for the treatment of obesity. According to a report by the researchers at the 16th European Obesity Conference, Tesofensine helps obese patients lose weight and subtracts the weight of their body and the right ingredients (fat). Tesofensine is a potential new weight loss medication that is currently undergoing clinical trials. Results from the Phase IIb clinical trials suggest that Tesofensine may be even more effective than the two slimming pills currently on the market: Xenical and Reductil.
